MYC and colorectal carcinoma: The activation of BrafV600E led to a rapid and persistent enrichment in MAPK-dependent gene signatures associated with proliferation and CRC progression, including a fetal-like gene signature, a Myc signature, a G2/M signature and an E2F target gene signature.